STOCK TITAN

Stereotaxis (STXS) director Menawat reports 46,948-share RSU award

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Stereotaxis, Inc. director Arun S. Menawat reported receiving a new equity award in the form of restricted share units of the company’s common stock. On 01/02/2026, he was granted 46,948 shares of common stock at a stated price of $0, increasing his directly held beneficial ownership to 992,457 shares after the transaction.

The filing explains that each restricted share unit represents the right to receive one share of common stock. These units vest on the earliest of three events: the fifth anniversary of the award date, the date his service as a director on the board ends, or the occurrence of a Change of Control as defined in the award documents.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Menawat Arun Swarup

(Last) (First) (Middle)
C/O STEREOTAXIS, INC.
710 NORTH TUCKER BOULEVARD; SUITE 110

(Street)
ST. LOUIS, MO 63101

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Stereotaxis, Inc. [ STXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/02/2026 A 46,948(1) A $0 992,457 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).
/s/ Kimberly R. Peery, Attorney-in Fact for Arun S. Menawat 01/02/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Stereotaxis (STXS) report for Arun S. Menawat?

The company reported that director Arun S. Menawat received a grant of 46,948 restricted share units of Stereotaxis common stock on 01/02/2026.

How many Stereotaxis (STXS) shares does Arun S. Menawat beneficially own after this transaction?

Following the reported grant, Arun S. Menawat beneficially owns 992,457 shares of Stereotaxis, Inc. common stock in direct ownership.

What are the vesting conditions for the new restricted share units at Stereotaxis (STXS)?

The restricted share units vest on the earliest of five years from the award date, the date the director’s board service ends, or a Change of Control as defined in the award documents.

What does each restricted share unit granted by Stereotaxis (STXS) represent?

Each restricted share unit represents a right to receive one share of Stereotaxis common stock upon vesting under the terms of the award.

What role does the reporting person hold at Stereotaxis (STXS)?

The reporting person, Arun S. Menawat, is identified in the filing as a Director of Stereotaxis, Inc.

Stereotaxis Ord

NYSE:STXS

STXS Rankings

STXS Latest News

STXS Latest SEC Filings

STXS Stock Data

214.65M
63.60M
30%
46.3%
3.28%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
ST.LOUIS